Marinella Clerico

Turin, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 90 publications

Correction: Enhancing the endocannabinoid system to treat residual disease in relapse-free multiple sclerosis.

Correction: Enhancing the endocannabinoid system to treat residual disease in relapse-free multiple sclerosis.

Journal: Frontiers in neurology
Published: March 13, 2026

Integrative Transcriptomics Uncovers IFN-β Signature and IFITM3 as Putative Molecular Mediator in MS.

Integrative Transcriptomics Uncovers IFN-β Signature and IFITM3 as Putative Molecular Mediator in MS.

Journal: International journal of molecular sciences
Published: February 24, 2026

Web-based family-reported outcomes to assess family functioning in multiple sclerosis: an Italian multicenter digital survey.

Web-based family-reported outcomes to assess family functioning in multiple sclerosis: an Italian multicenter digital survey.

Journal: International journal of medical informatics
Published: January 25, 2026

The Role of Lifestyle Factors in Multiple Sclerosis: An Integrative Perspective.

The Role of Lifestyle Factors in Multiple Sclerosis: An Integrative Perspective.

Journal: Brain sciences
Published: December 20, 2025

The Hidden Players in Multiple Sclerosis Nutrition: A Narrative Review on the Influence of Vitamins, Polyphenols, Salt, and Essential Metals on Disease and Gut Microbiota.

The Hidden Players in Multiple Sclerosis Nutrition: A Narrative Review on the Influence of Vitamins, Polyphenols, Salt, and Essential Metals on Disease and Gut Microbiota.

Journal: Nutrients
Published: December 05, 2025

Enhancing the endocannabinoid system to treat residual disease in relapse-free multiple sclerosis.

Enhancing the endocannabinoid system to treat residual disease in relapse-free multiple sclerosis.

Journal: Frontiers in neurology
Published: November 15, 2025

Linking Nutrients to Multiple Sclerosis Pathogenesis: Biological Evidence and Clinical Implications.

Linking Nutrients to Multiple Sclerosis Pathogenesis: Biological Evidence and Clinical Implications.

Journal: Nutrients
Published: September 11, 2025

Gut microbiome profiling at multiple sclerosis onset as a potential early prognostic marker of disease course: evidence from an observational cohort study.

Gut microbiome profiling at multiple sclerosis onset as a potential early prognostic marker of disease course: evidence from an observational cohort study.

Journal: EBioMedicine
Published: June 10, 2025

Safety assessment of switching from fingolimod to siponimod: An Italian multicenter prospective study.

Safety assessment of switching from fingolimod to siponimod: An Italian multicenter prospective study.

Journal: Journal of the neurological sciences
Published: February 02, 2025

Investigating depression in multiple sclerosis: an Italian Delphi consensus on clinical manifestations, diagnosis and treatment.

Investigating depression in multiple sclerosis: an Italian Delphi consensus on clinical manifestations, diagnosis and treatment.

Journal: Frontiers in psychiatry
Published: January 08, 2025

Behind the scenes: exploring neurological journal editors' work habits, decisions, and potential sources of conflict of interest.

Behind the scenes: exploring neurological journal editors' work habits, decisions, and potential sources of conflict of interest.

Journal: Journal of neurology
Published: July 26, 2024

Disease-Modifying Symptomatic Treatment (DMST): The Potential Role of Vortioxetine in the Treatment of Depression in Patients with Multiple Sclerosis.

Disease-Modifying Symptomatic Treatment (DMST): The Potential Role of Vortioxetine in the Treatment of Depression in Patients with Multiple Sclerosis.

Journal: Current neuropharmacology
Published: April 22, 2024
Showing 1-12 of 90

Last Updated: 09/26/2026